S100A8 and juvenile idiopathic arthritis: Whether MRP8/14 is also associated with response to TNF-alpha inhibitors in patients with non-systemic JIA, or can predict flares after discontinuation of etanercept after successful treatment when clinical remission is achieved, is unknown.